郑佳音

作品数:3被引量:3H指数:1
导出分析报告
供职机构:首都医科大学更多>>
发文主题:INHIBITORNDM-1BACTERIALMETALLO-Β-LACTAMASETHROUGHPUT更多>>
发文领域:医药卫生更多>>
发文期刊:《Journal of Chinese Pharmaceutical Sciences》更多>>
所获基金:国家自然科学基金国家高技术研究发展计划更多>>
-

检索结果分析

署名顺序

  • 全部
  • 第一作者
结果分析中...
条 记 录,以下是1-2
视图:
排序:
KL-0153, a novel inhibitor of Pseudomonas aeruginosa MexAB-OprM efflux pump
《Journal of Chinese Pharmaceutical Sciences》2016年第4期310-315,共6页刘忆霜 王颖 郑佳音 李兴华 关艳 黄树超 肖春玲 
National High-tech R&D Program(863 Program,Grant No.2015AA020911);National Natural Science Foundation(Grant No.81102353)
Pseudomonas aeruginosa is an opportunistic pathogen that contributes to high morbidity and mortality. MexAB-OprM is the main efflux pump among the Resistance-Nodulation-Division family multi-drug effiux systems, which...
关键词:Pseudomonas aeruginosa Multi-drug resistance Effiux pump MEXAB-OPRM INHIBITOR Antibacterial drug synergistic agent 
Establishment and application of the screening model of the Mycobacterium tuberculosis β-lactamase BlaC inhibitors被引量:1
《Journal of Chinese Pharmaceutical Sciences》2016年第3期189-195,共7页刘忆霜 郑佳音 黄树超 关艳 肖春玲 
Fundamental Research Funds for Central Public Welfare Research Institutes(Grant No.2015PT350001);National Major Scientific and Technological Special Project for “Significant New Drugs Development”(Grant No.2015ZX09102007-009)
With the continuous emergence and rapid spread of multidrug-resistant and extensively-drug-resistant Mycobacterium tuberculosis strains, it is imperative to develop novel therapies against this bacterium. The intrins...
关键词:Mycobacterium tuberculosis Β-LACTAMASE BlaC High-through screening model Anti-tuberculosis drug synergistic agents 
检索报告 对象比较 聚类工具 使用帮助 返回顶部